Purna
Purna is an independent Belgian company established in 1986, providing contract services for the development and manufacturing of powders, semi-solid and liquid pharmaceutical products that meet GXP standards as well as specific customer related requirements. Over the years, Purna has established a reputation for excellence and a global presence in the pharmaceutical industry, resulting in the status of preferred partner for most of the top-10 pharmaceutical multinationals. Purna’s agile and efficient operating model allows the company to successfully serve small start-ups with the same level of professional service that is afforded to its multinational pharmaceutical customers.
Creafund exited its stake in Purna in 2026 towards Ampersand Capital Partners.
